Yatharth Hospitals reported a healthy revenue growth which was marginally below our estimates, while EBITDA was slightly below our expectations due to increased employee cost on recruiting leading doctors in the NCR region during Q2FY25
J.B. Chemicals is well-positioned to capitalize on immediate growth opportunities. Buy for target price of ₹2217 (19% upside): SMIFS
JBCP is well-positioned to capitalize on immediate growth opportunities. We expect 29% EPS CAGR over FY24-26E aided by 1) Strong growth from domestic business (CAGR of 15% FY24-FY27E), 2) ~30% growth over FY24-FY26E from acquired portfolios, 3) scaling up of high margin CDMO business on the back of new therapy launches and 4) robust FCF generation. We maintain our Buy rating on the stock with similar target price to Rs 2,217, valuing the company at 36x Sept’26E EPS
Aptus Value Housing Finance has significant headroom for growth. Buy for target price of ₹425 (25% upside): Systematix Research
APTUS reported a healthy quarter led by pick up in disbursements, steady spreads and asset quality. Management remained confident of maintaining strong AUM growth and stable asset quality in FY25. APTUS’s core strengths and prudent underwriting practice provide comfort. At CMP the stock is trading at 3.4x FY26 BV with RoA/ RoE of 7%/ 21%. We maintain our BUY rating on the stock with an unchanged target price of Rs. 425, valuing the company at 4.2x FY26E book value.
The Axis Top Picks Basket delivered a return of 11.6% in the last six months against the 7.5% returns posted by Nifty 50 over the same period
![The Axis Top Picks Basket delivered a return of 11.6% in the last six months against the 7.5% returns posted by Nifty 50 over the same period](https://rakesh-jhunjhunwala.in/wp-content/uploads/Axis-Securities-Top-Picks-.jpg)
The Axis Top Picks Basket delivered a return of 11.6% in the last six months against the 7.5% returns posted by Nifty 50 over the same period. Amidst a highly volatile month of Oct’24 that witnessed notably mixed performance across sectors, market caps, and style indices, the Axis Top Picks basket declined by 4.4% in Oct’24 (Till 1st Nov’24 closing) but managed to beat the market performance as the benchmark Nifty 50 declined by 5.8% over the same period.
DLF has a strong growth story given its robust launch pipeline. Buy for target price of ₹1081 (30% upside): Nuvama
We remain upbeat on DLFU’s growth prospects on strong sectoral tailwinds (industry-wide consolidation, record low inventory in its home market, and greater preference for branded luxury inventory), an extensive launch pipeline, and expansion in its annuity portfolio. A strong Balance Sheet, with consistent cash flow, lends comfort. We revise our TP to INR1,081 (INR1,087 earlier). Maintain ‘BUY’.
IPO: Swiggy is well recognized as a leader and a pioneer in hyperlocal commerce innovation. Subscribe to the IPO: SBI Securities
![IPO: Swiggy is well recognized as a leader and a pioneer in hyperlocal commerce innovation. Subscribe to the IPO: SBI Securities](https://rakesh-jhunjhunwala.in/wp-content/uploads/IPO-Swiggy-.jpg)
Swiggy Ltd (Swiggy) is a new-age technology company offering users an easyto-use convenience platform accessible through a unified app to browse, select, order & pay for food, grocery & household items (Instamart) and have their orders delivered to their doorstep through on-demand delivery partner network (Genie)
Recent Comments